ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00825942
Recruitment Status : Unknown
Verified April 2009 by Chakshu Research, Inc..
Recruitment status was:  Active, not recruiting
First Posted : January 21, 2009
Last Update Posted : April 17, 2009
Sponsor:
Information provided by:
Chakshu Research, Inc.

Brief Summary:
To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Condition or disease Intervention/treatment Phase
Asteroid Hyalosis Drug: C-KAD Ophthalmic Solution Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis
Study Start Date : July 2008
Estimated Primary Completion Date : October 2009
Estimated Study Completion Date : November 2009

Arm Intervention/treatment
Experimental: C-KAD Ophthalmic Solution Drug: C-KAD Ophthalmic Solution
4 drops applied daily for 180 days




Primary Outcome Measures :
  1. Reduction in the number of asteroid bodies [ Time Frame: 180 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Presence of asteroid hyalosis

Exclusion Criteria:

  • Active ocular infection
  • Glaucoma
  • Ocular hypertension
  • Ocular inflammatory disorders

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00825942


Locations
United States, California
Mountain View Optometry and Contact Lens Clinic
Mountain View, California, United States, 94041
Sponsors and Collaborators
Chakshu Research, Inc.
Investigators
Study Director: Ira Wong, MD Chakshu Research, Inc.

Responsible Party: Ellen Hoogeveen /Associate Director, Clinical & Regulatory Affairs, Chakshu Research, Inc.
ClinicalTrials.gov Identifier: NCT00825942     History of Changes
Other Study ID Numbers: PCK-0108
First Posted: January 21, 2009    Key Record Dates
Last Update Posted: April 17, 2009
Last Verified: April 2009

Keywords provided by Chakshu Research, Inc.:
Asteroid hyalosis
Opthalmic Study

Additional relevant MeSH terms:
Pharmaceutical Solutions
Ophthalmic Solutions